COHANCE.NS Overview

Company Profile

Related stocks

JUBLPHARMA.BO • India

JUBILANT PHARMOVA LIMITED

931.2 INR

1.52B USD 1Y -14.2%

CAPLIPOINT.BO • India

CAPLIN POINT LABORATORIES LTD.

2,459.55 INR

1.93B USD 1Y +27.1%

AKUMS.NS • India

AKUMS DRUGS AND PHARMA L

751.85 INR

1.19B USD 1Y +78.6%

APLLTD.NS • India

ALEMBIC PHARMA LTD

800.95 INR

1.63B USD 1Y -14%

SHILPAMED.BO • India

SHILPA MEDICARE LTD.

1,020.35 INR

2.06B USD 1Y +187.4%

ASTRAZEN.BO • India

ASTRAZENECA PHARMA INDIA LTD.

5,831.85 INR

1.51B USD 1Y -38.5%

PPLPHARMA.NS • India

PIRAMAL PHARMA LIMITED

196.88 INR

2.7B USD 1Y -0.4%

ALIVUS.NS • India

ALIVUS LIFE SCIENCES LTD

1,326.3 INR

1.68B USD 1Y +45.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

India

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

37.0% p.a.

Max Drawdown (5Y)

-79.0%

Sharpe Ratio (5Y)

-0.19

Beta Factor

0.62

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 161.5 (Elevated multiple compression risk)

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Elevated Short-Term Volatility: 3Y volatility (41.9%) is noticeably higher than the 5Y average (37.0%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.0% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -79.0% in the extended horizon.